Literature DB >> 32294824

[An urgent call for raising the scientific rigorousness of clinical trials on COVID-19].

F Chen1, Y T Hao2, Z J Zhang3, J L Tang4, J L Xia5, S Y Zhan6, Y Zhao1, Z C Du2, Y Y Wei1, S P Shen1, Q W Jiang3, L M Li6.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32294824     DOI： 10.3760/cma.j.issn.0254-6450.2020.03.004

Source DB:  PubMed          Journal:  Zhonghua Liu Xing Bing Xue Za Zhi        ISSN： 0254-6450


× No keyword cloud information.
  6 in total

1.  Improving Stem Cell Clinical Trial Design and Conduct: Development of a Quality Assessment Tool for Stem Cell Clinical Trials.

Authors:  Yixuan Li; Li Xie; Jie Wang; Jinghang He; Ying Qian; Weituo Zhang; Zhaohui Wu; Biyun Qian
Journal:  Stem Cells Int       Date:  2020-11-07       Impact factor: 5.443

2.  Cardiovascular Impairment in COVID-19: Learning From Current Options for Cardiovascular Anti-Inflammatory Therapy.

Authors:  Lun Wang; Yang Zhang; Shuyang Zhang
Journal:  Front Cardiovasc Med       Date:  2020-04-30

3.  Appealing for efficient, well organized clinical trials on COVID-19.

Authors:  Yang Zhao; Yongyue Wei; Sipeng Shen; Mingzhi Zhang; Feng Chen
Journal:  Ann Transl Med       Date:  2020-05

4.  Challenges and strategies to research ethics in conducting COVID-19 research.

Authors:  Xitao Ma; Yanqiao Wang; Tian Gao; Qing He; Yan He; Rensong Yue; Fengming You; Jianyuan Tang
Journal:  J Evid Based Med       Date:  2020-05-22

5.  [A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19].

Authors:  Jun Chen; Danping Liu; Li Liu; Ping Liu; Qingnian Xu; Lu Xia; Yun Ling; Dan Huang; Shuli Song; Dandan Zhang; Zhiping Qian; Tao Li; Yinzhong Shen; Hongzhou Lu
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2020-05-25

6.  Comments on Zhang et al: Clinical trial analysis of 2019-nCoV therapy registered in China.

Authors:  Yang Yu; Qianling Shi; Hao Chen
Journal:  J Med Virol       Date:  2020-04-15       Impact factor: 2.327
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.